These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 191199)

  • 41. Infection of rabbit alveolar macrophages with a neurotropic vaccinia virus strain in vitro.
    Benda R; Danes L; Cinátl J
    Acta Virol; 1970 Sep; 14(5):353-61. PubMed ID: 4394660
    [No Abstract]   [Full Text] [Related]  

  • 42. Interaction between encephalomyocarditis (EMC) virus and polio-virus in cultured cells. Increase in the number of EMC virus-producing cells.
    Shirman GA; Maslova SV; Gavrilovskaya IN; Agol VI
    Acta Virol; 1972 Mar; 16(2):175. PubMed ID: 4401077
    [No Abstract]   [Full Text] [Related]  

  • 43. Rapid micro-radioimmunoassay for the measurement of antiviral antibody.
    Rosenthal JD; Hayashi K; Notkins AL
    J Immunol; 1972 Jul; 109(1):171-3. PubMed ID: 4338438
    [No Abstract]   [Full Text] [Related]  

  • 44. [Fluorescent immunoglobulins to the herpes simplex virus from rat immune ascitic fluids].
    Stanislavskaia VK; Blizniuk VV
    Vopr Virusol; 1986; 31(2):245-8. PubMed ID: 3014755
    [No Abstract]   [Full Text] [Related]  

  • 45. Soluble antigens of vaccinia virus. Note I. Chemical and biological properties. Immunogenic capacity.
    Mihăilescu R; Olinescu A; Popa L; Stavri H; Iancu L
    Arch Roum Pathol Exp Microbiol; 1987; 46(1):35-46. PubMed ID: 2449147
    [No Abstract]   [Full Text] [Related]  

  • 46. Vaccinia virus expression vectors.
    Moss B; Flexner C
    Annu Rev Immunol; 1987; 5():305-24. PubMed ID: 2439103
    [No Abstract]   [Full Text] [Related]  

  • 47. Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity.
    Wachsman M; Luo JH; Aurelian L; Perkus ME; Paoletti E
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2513-20. PubMed ID: 2550579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the antiviral activity in vitro of some non-steroidal anti-inflammatory drugs.
    Inglot AD
    J Gen Virol; 1969 Mar; 4(2):203-14. PubMed ID: 4306296
    [No Abstract]   [Full Text] [Related]  

  • 49. Detection of encephalomyocarditis virus infection in animal cells by gas liquid chromatography.
    Levanon A; Klibansky Y; Kohn A
    Experientia; 1973 Oct; 29(10):1305-7. PubMed ID: 4357193
    [No Abstract]   [Full Text] [Related]  

  • 50. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparative electron-microscopic studies on mouse peritoneal macrophages after intraperitoneal administration of sheep or self erythrocytes].
    Barten M; Schmitt E; Tessmann D; Bienengräber A
    Allerg Immunol (Leipz); 1973; 19(2-4):196-8. PubMed ID: 4281625
    [No Abstract]   [Full Text] [Related]  

  • 52. The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Balzarini J; De Clercq E
    Biochem Biophys Res Commun; 1989 Feb; 159(1):61-7. PubMed ID: 2538128
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance of visna virus to interferon.
    Carroll D; Ventura P; Haase A; Rinaldo CR; Overall JC; Glasgow LA
    J Infect Dis; 1978 Nov; 138(5):614-7. PubMed ID: 213502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of natural killer cell cytotoxicity from bone marrow cells cocultivated with immune peritoneal macrophages.
    Chapes SK; Fan SS; Cummins JM; Tompkins WA
    J Reticuloendothel Soc; 1981 May; 29(5):341-55. PubMed ID: 6165823
    [No Abstract]   [Full Text] [Related]  

  • 55. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility.
    Stutman O; Paige CJ; Figarella EF
    J Immunol; 1978 Nov; 121(5):1819-26. PubMed ID: 712067
    [No Abstract]   [Full Text] [Related]  

  • 56. Prevention of cell-to-cell spread of herpes simplex virus by leukocytes.
    Lodmell DL; Niwa A; Hayashi K; Notkins AL
    J Exp Med; 1973 Mar; 137(3):706-20. PubMed ID: 4347596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Testing the immunity to orthopoxviruses in the white mouse with vaccinia virus].
    Czerny CP; Mahnel H; Hornstein O
    Zentralbl Veterinarmed B; 1989 Mar; 36(2):100-12. PubMed ID: 2750360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antiviral activity and metal ion-binding properties of some 2-hydroxy-3-methoxyphenyl acylhydrazones.
    Carcelli M; Fisicaro E; Compari C; Contardi L; Rogolino D; Solinas C; Stevaert A; Naesens L
    Biometals; 2018 Feb; 31(1):81-89. PubMed ID: 29209895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis of some acylphosphonate thiosemicarbazones and evaluation of their antiviral activity.
    Breuer E; Karaman R; Zaher H; Katz E
    Drug Des Discov; 1994 Jan; 11(1):39-46. PubMed ID: 8068818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New isothiazole derivatives. II. Cytotoxicity and antiviral activity in tissue cultures.
    Inglot AD; Machoń Z; Wolna E; Wilimowski M; Prandota J
    Arch Immunol Ther Exp (Warsz); 1973; 21(6):891-902. PubMed ID: 4361627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.